Editorial policy
On this page
What we compare
Make the differences between five molecules legible in one screen, and never imply an equivalence the data does not support. That last part is the reason this site compares evidence before presenting seller options.
Where the molecule figures come from
Half-lives, mechanisms and regulatory status come from published sources, and each one is cited on the page it appears on. Where the literature gives a range, we print the range. we do not collapse a range to a midpoint to make a chart tidier — the spread is usually the information. Where two sources disagree, we print both and say they disagree, rather than picking the one that reads better.
Regulatory status is stated and not editorialised. An unapproved molecule is not thereby a bad one, and an approved one is not thereby better. we state what the record is.
How sellers are found
By searching for the molecule the way a buyer would, and by working through the telehealth companies that actually dispense it. A seller is included when its published listings help compare molecules, explain different billing terms, or illustrate information a buyer still needs to request. Payment is not required for inclusion. Companies that pay us nothing are listed alongside the ones that do, in the same format, and their write-ups are not systematically less generous.
How prices are read
Prices come from the provider’s own product information. We retain the source reading and original terms. Each offer identifies its billing period and any published supply details; missing quantities remain unknown. Starting prices, recurring rates and prepaid totals are labeled separately because they represent different commitments.
Prices are drug-scoped. A figure read off a seller’s GLP-1 page is not a price for sermorelin, and we do not carry one across. If a price is only visible after an intake, we state so rather than leaving the cell empty in a way that implies the seller publishes nothing.
How often figures are re-checked
The revision date marks a substantive page update; it does not mean every recorded price is a newly verified offer. We retain the original source readings internally and do not promise a fixed rechecking schedule. Confirm the current price, medication quantity and terms before paying.
What a commercial relationship changes
It does not change the comparison tables. Mechanism, half-life, selectivity and regulatory status belong to a molecule, not to a seller, and no seller can buy a cell in that grid. No paid button sits inside it or on top of it.
It does not change the price we print, remove a competitor, or buy a kinder sentence. What it does change is that the site gets paid, and one order: in the seller cards near the top of a page, a partner that sells that page’s molecules comes first. That is why every paid button carries a label directly beneath it saying so. Which sellers pay, and what that changes, is on the disclosure page.
What we will not publish
- A clinical claim dressed as a comparison. Nothing here is medical advice, and nothing here is written as though it were.
- A price without its cycle and the dose it buys.
- A figure without a source, or a source without a date.
- An absence stated as a fact without saying how widely we looked for it.
- A generated image, a stock photograph of a patient, or an author portrait.
Corrections
We maintain the corrections log. If something here is wrong, write to editor@sermorelincompare.com and the fix gets published on the corrections page, dated, saying what was wrong and when.